GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Meihao Medical Group Co Ltd (HKSE:01947) » Definitions » EBIT

Meihao Medical Group Co (HKSE:01947) EBIT : HK$-18.65 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Meihao Medical Group Co EBIT?

Meihao Medical Group Co's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was HK$-14.69 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-18.65 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Meihao Medical Group Co's annualized ROC % for the quarter that ended in Jun. 2024 was -36.20%. Meihao Medical Group Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -44.46%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Meihao Medical Group Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -17.52%.


Meihao Medical Group Co EBIT Historical Data

The historical data trend for Meihao Medical Group Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meihao Medical Group Co EBIT Chart

Meihao Medical Group Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
26.79 30.85 56.49 47.00 -6.04

Meihao Medical Group Co Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EBIT Get a 7-Day Free Trial 19.24 28.68 -2.08 -3.96 -14.69

Competitive Comparison of Meihao Medical Group Co's EBIT

For the Medical Instruments & Supplies subindustry, Meihao Medical Group Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Meihao Medical Group Co's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Meihao Medical Group Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Meihao Medical Group Co's EV-to-EBIT falls into.


;
;

Meihao Medical Group Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-18.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Meihao Medical Group Co  (HKSE:01947) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Meihao Medical Group Co's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=-35.144 * ( 1 - -4.88% )/( (106.402 + 97.263)/ 2 )
=-36.8590272/101.8325
=-36.20 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=254.224 - 22.748 - ( 155.285 - max(0, 41.519 - 166.593+155.285))
=106.402

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=241.604 - 34.534 - ( 139.782 - max(0, 47.642 - 157.449+139.782))
=97.263

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Meihao Medical Group Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-29.382/( ( (67.438 + max(-25.209, 0)) + (64.721 + max(-34.16, 0)) )/ 2 )
=-29.382/( ( 67.438 + 64.721 )/ 2 )
=-29.382/66.0795
=-44.46 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.863 + 2.741 + 3.077) - (22.748 + 0 + 9.142)
=-25.209

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.418 + 3.025 + 0) - (34.534 + 0 + 4.069)
=-34.16

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Meihao Medical Group Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2024 )
=-18.65/106.424
=-17.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Meihao Medical Group Co EBIT Related Terms

Thank you for viewing the detailed overview of Meihao Medical Group Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Meihao Medical Group Co Business Description

Traded in Other Exchanges
N/A
Address
197 Fuqian Street, Lucheng District, Zhejiang Province, Wenzhou, CHN
Meihao Medical Group Co Ltd is a dental service provider in Wenzhou. It offers services to individuals and covers principally four dental sectors: general dentistry, reparative dentistry, implant dentistry, orthodontics, and cosmetic dentistry.
Executives
Wang Xiaomin
Jtc (china) Co., Ltd 2101 Beneficial owner
Ze Tian Sen Hong You Xian Gong Si 2301 Trustee
Zheng Man
Jian Chi Kang Zhong Guo You Xian Gong Si 2101 Beneficial owner
Mei Hao Zhong Guo You Xian Gong Si 2101 Beneficial owner
Rui Kang Zhong Guo You Xian Gong Si 2101 Beneficial owner

Meihao Medical Group Co Headlines

No Headlines